Head-to-head · Cost-Efficiency Index
REMEVi vs Pepti
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
REMEVi
Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.
Visit REMEViPepti
Shoppers who want to see the price of every dose step before they start, with no membership fee on top.
Visit PeptiThe verdict
REMEVi and Pepti tie on the Cost-Efficiency Index at 80/100, so neither wins outright on the numbers, so choose on fit. REMEVi: Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language. Pepti: Shoppers who want to see the price of every dose step before they start, with no membership fee on top.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs REMEVi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | REMEVi | Pepti |
|---|---|---|
| Cost-Efficiency Index | 80/100 | 80/100 |
| Semaglutide / mo | $219/mo | $99/mo0.25 mg starting dose, compounded; $109–$199 at higher doses |
| Tirzepatide / mo | $319/mo | $159/mo2.5 mg starting dose, compounded; $179–$319 at higher doses |
| Semaglutide / yr (modeled) | $2,628 | $1,28713 charges |
| Tirzepatide / yr (modeled) | $3,828 | $2,06713 charges |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #34 | #38 |
REMEVi
80/100Where the value is
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
The tradeoffs
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
Pepti
80/100Where the value is
- Every dose has its own published price: semaglutide runs $99 to $199 and tirzepatide $159 to $319
- No membership fee; the medication price includes physician review, dose adjustments and free shipping
- Names a reviewing physician and a dispensing pharmacy, Olympia Pharmacy
The tradeoffs
- The price rises as your dose goes up, so the $99 starting figure covers only the first step of semaglutide
- It bills every 28 days rather than monthly, which adds up to 13 charges a year
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.